Literature DB >> 17652589

Ca2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation.

Shogo Ishiuchi1, Yukari Yoshida, Kenichi Sugawara, Masanori Aihara, Toshiyuki Ohtani, Takashi Watanabe, Nobuhito Saito, Keisuke Tsuzuki, Haruo Okado, Akiko Miwa, Yoichi Nakazato, Seiji Ozawa.   

Abstract

Evidence has been accumulated that glioblastoma cells release and exploit glutamate for proliferation and migration by autocrine or paracrine loops through Ca2+-permeable AMPA-type glutamate receptors. Here, we show that Ca2+ signaling mediated by AMPA receptor regulates the growth and motility of glioblastoma cells via activation of Akt. Ca2+ supplied through Ca2+-permeable AMPA receptor phosphorylated Akt at Ser-473, thereby facilitating proliferation and mobility. A dominant-negative form of Akt inhibited cell proliferation and migration accelerated by overexpression of Ca2+-permeable AMPA receptor. In contrast, introduction of a constitutively active form of Akt rescued tumor cells from apoptosis induced by the conversion of Ca2+-permeable AMPA receptor to Ca2+-impermeable receptors by the delivery of GluR2 cDNA. Therefore, Akt functions as downstream effectors for Ca2+-signaling mediated by AMPA receptor in glioblastoma cells. The activation of the glutamate-AMPA receptor-Akt pathway may contribute to the high degree of anaplasia and invasive growth of human glioblastoma. This novel pathway might give an alternative therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652589      PMCID: PMC6672718          DOI: 10.1523/JNEUROSCI.2180-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  78 in total

Review 1.  Glutamate and the biology of gliomas.

Authors:  John de Groot; Harald Sontheimer
Journal:  Glia       Date:  2010-12-29       Impact factor: 7.452

Review 2.  Neuronal Activity in Ontogeny and Oncology.

Authors:  Humsa Venkatesh; Michelle Monje
Journal:  Trends Cancer       Date:  2017-02-13

3.  Atorvastatin Promotes Cytotoxicity and Reduces Migration and Proliferation of Human A172 Glioma Cells.

Authors:  Karen A Oliveira; Tharine Dal-Cim; Flávia G Lopes; Fabiana K Ludka; Cláudia B Nedel; Carla I Tasca
Journal:  Mol Neurobiol       Date:  2017-02-08       Impact factor: 5.590

Review 4.  Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets.

Authors:  Razina Aziz-Bose; Michelle Monje
Journal:  Curr Opin Oncol       Date:  2019-11       Impact factor: 3.645

5.  Stereochemical and structural effects of (2R,6R)-hydroxynorketamine on the mitochondrial metabolome in PC-12 cells.

Authors:  Andréa T Faccio; Francisco J Ruperez; Nagendra S Singh; Santiago Angulo; Marina F M Tavares; Michel Bernier; Coral Barbas; Irving W Wainer
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-03-09       Impact factor: 3.770

6.  Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion.

Authors:  Humsa S Venkatesh; Tessa B Johung; Viola Caretti; Alyssa Noll; Yujie Tang; Surya Nagaraja; Erin M Gibson; Christopher W Mount; Jai Polepalli; Siddhartha S Mitra; Pamelyn J Woo; Robert C Malenka; Hannes Vogel; Markus Bredel; Parag Mallick; Michelle Monje
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

Review 7.  Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.

Authors:  Evan Noch; Kamel Khalili
Journal:  Cancer Biol Ther       Date:  2009-10       Impact factor: 4.742

8.  Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.

Authors:  Stefania Maraka; Morris D Groves; Aaron G Mammoser; Isaac Melguizo-Gavilanes; Charles A Conrad; Ivo W Tremont-Lukats; Monica E Loghin; Barbara J O'Brien; Vinay K Puduvalli; Erik P Sulman; Kenneth R Hess; Kenneth D Aldape; Mark R Gilbert; John F de Groot; W K Alfred Yung; Marta Penas-Prado
Journal:  Cancer       Date:  2018-10-25       Impact factor: 6.860

Review 9.  A role for glutamate in growth and invasion of primary brain tumors.

Authors:  Harald Sontheimer
Journal:  J Neurochem       Date:  2008-02-14       Impact factor: 5.372

10.  Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4.

Authors:  Christina A von Roemeling; Derek C Radisky; Laura A Marlow; Simon J Cooper; Stefan K Grebe; Panagiotis Z Anastasiadis; Han W Tun; John A Copland
Journal:  Cancer Res       Date:  2014-06-24       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.